RESULTS OF PARACHIZOMETRIC TUMOR REMOVAL SURGERY FOR PRIMARY HYPERPARATHYROIDISM AT THE THORACIC SURGERY DEPARTMENT OF BACH MAI HOSPITAL PERIOD 2024-2025

Vu Anh Tuan1, Nguyen Van Minh2, Hoang Vu1, Pham Quang Huy1
1 Bach Mai Hospital
2 Bach Mai Hospial

Main Article Content

Abstract

Objective: To describe the clinical and paraclinical symptoms and early postoperative outcomes of primary hyperparathyroidism treated with parathyroidectomy at the Thoracic Surgery Department of Bach Mai Hospital during the period 2024-2025.


Subjects and methods: A retrospective and prospective descriptive study was conducted on 38 eligible patients who underwent surgery at the Thoracic Surgery Department of Bach Mai Hospital from March 2024 to June 2025.


Results: The female/male ratio was 2.8/1, the average age was 58.68 years, the average surgical time was 56.18 ± 13.73 minutes, 1/38 patients had parathyroid cancer, all patients showed a reduction in parathyroid hormone and blood calcium levels after surgery, there were no cases of bleeding, and no deaths.


Conclusion: Minimally invasive surgical resection of parathyroid tumors for the treatment of primary hyperparathyroidism is a very safe and effective surgical method.

Article Details

References

[1] Brandi M.L. Primary hyperparathyroidism. Parathyroid Disorders: Focusing on Unmet Needs. Front Horm Res, 2019, 51: 1-12. doi: 10.1159/000491034.
[2] Rao S.D. Epidemiology of parathyroid disorders. Best Practice Research Clinical Endocrinology Metabolism, 2018, 32 (6): 773-780. doi: 10.1016/j.beem.2018.12.003.
[3] Silva B.C, Cusano N.E, Bilezikian J.P. Primary hyperparathyroidism. Best Practice & Research Clinical Endocrinology & Metabolism, 2018, 32 (5): 593-607.
[4] Yeh M.W, Ituarte P.H.G, Zhou H.C et al. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab, 2013, 98 (3), 1122-1129.
[5] Vũ Trung Lương. Nghiên cứu đặc điểm lâm sàng, cận lâm sàng và đánh giá kết quả phẫu thuật u tuyến cận giáp lành tính. Luận án tiến sĩ y học, Trường Đại học Y Hà Nội, 2021.
[6] Nguyễn Ánh Ngọc. Nghiên cứu đặc điểm lâm sàng, cận lâm sàng và kết quả điều trị ngoại khoa cường tuyến cận giáp. Luận án tiến sĩ y học, Viện Nghiên cứu Khoa học Y Dược lâm sàng 108, 2024.
[7] Griebeler M.L, Kearns A.E, Ryu E et al. Secular trends in the incidence of primary hyperparathyroidism over five decades (1965-2010). Bone, 2015, 73: 1-7.
[8] Hamidi S, Soltani A, Hedayat A et al. Primary hyperparathyroidism: A review of 177 cases. Medical Science Monitor, 2006, 12 (2): CR86-89.
[9] Levin K.E, Galante M, Clark O.H. Parathyroid carcinoma versus parathyroid adenoma in patients with profound hypercalcemia. Surgery, 1987, 101 (6): 649-660.
[10] Zhao L, Liu J, He X.Y et al. the changing clinical patterns of primary hyperparathyroidism in Chinese patients: Data from 2000 to 2010 in a single clinical center. J Clin Endocrinol Metab, 2013, 98 (2): 721-728. doi: 10.1210/jc.2012-2914.